Generic drugs market

Generic Drugs Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024

REPORT DESCRIPTION Generic Drugs Market : Overview Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017 and 2020, which is expected to drive growth of the generic drugs market. Competition has increased significantly in the global generics market with many Asia Pacific companies entering the developed markets such as the U.S., Germany, France, and UK. The last couple of years has witnessed as spurt in mergers and acquisitions between generic drug manufacturers, with major players focusing on enhancing their product portfolio through such inorganic strategies. For instance, Teva Pharmaceutical Industries Pvt. Ltd., Pfizer, Inc., Mylan, Sun Pharmaceutical, and Fresenius Kabi entered into acquisitions to increase their revenue share in the generic drugs market.

REPORT DESCRIPTION Generic Drugs Market : Competitive Analysis Top 10 generic drug manufacturers, in terms of revenue, in 2016, are as follows: 1.TEVA PHARMACEUTICAL INDUSTRIES 2.MYLAN N.V. 3.NOVARTIS INTERNATIONAL AG 4.PFIZER, INC. 5.ALLERGAN PLC 6.SUN PHARMACEUTICALS 7.FRESENIUS KABI 8.ENDO INTERNATIONAL 9.LUPIN LIMITED 10.SANOFI Ask For Table Of Content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1084 Â© Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Generic Drugs Market : Growth Teva Pharmaceuticals Industries strengthened its pole position in the generic drugs market through acquisition of the generic segment of Allergan, plc for US$ 40.5 billion in August 2016. This resulted in significant growth in revenue contribution of its generic drug segment, pegged at US$ 9.5 billion in 2016. Mylan ranks second in the list of generic drug manufacturers, and this is due to the acquisition valued at US$ 7.2 Bn of Swedenâ&#x20AC;&#x2122;s Meda by Mylan, in year 2016. This also aided Mylan to increase its sales of over-the-counter drugs and expand its presence in new emerging markets such as China, Southeast Asia, Russia, and the Middle East.

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

CUSTOMIZED RESEARCH CONSULT STUDIES

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

MEDICAL DEVICES

MEDICAL IMAGING

OUR CLIENTS        

Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.

HEALTHCARE IT

PHARMACEUTICAL

ABOUT COHERENT MARKET INSIGHTS

KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+ Insights Published Per Year

150+ Consulting Projects Till Date

125+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEAR CH

EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT

Clients Worldwide Per Year

110+

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 ÂŠ Coherent market Insights. All Rights Reserved

Turn static files into dynamic content formats.

Create a flipbook